BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8789768)

  • 1. Effective treatment of acute hyperkalaemia in childhood by short-term infusion of salbutamol.
    Kemper MJ; Harps E; Hellwege HH; Müller-Wiefel DE
    Eur J Pediatr; 1996 Jun; 155(6):495-7. PubMed ID: 8789768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperkalemia: therapeutic options in acute and chronic renal failure.
    Kemper MJ; Harps E; Müller-Wiefel DE
    Clin Nephrol; 1996 Jul; 46(1):67-9. PubMed ID: 8832156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hyperkalaemia using intravenous and nebulised salbutamol.
    McClure RJ; Prasad VK; Brocklebank JT
    Arch Dis Child; 1994 Feb; 70(2):126-8. PubMed ID: 8129434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salbutamol for hyperkalaemia in children.
    Helfrich E; de Vries TW; van Roon EN
    Acta Paediatr; 2001 Nov; 90(11):1213-6. PubMed ID: 11808886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hyperkalaemia with intravenous salbutamol.
    Murdoch IA; Dos Anjos R; Haycock GB
    Arch Dis Child; 1991 Apr; 66(4):527-8. PubMed ID: 2031614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches.
    Ngugi NN; McLigeyo SO; Kayima JK
    East Afr Med J; 1997 Aug; 74(8):503-9. PubMed ID: 9487416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hyperkalaemia in renal failure with salbutamol inhalation.
    Montoliu J; Almirall J; Ponz E; Campistol JM; Revert L
    J Intern Med; 1990 Jul; 228(1):35-7. PubMed ID: 2384735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salbutamol infusion to treat neonatal hyperkalaemia.
    Greenough A; Emery EF; Brooker R; Gamsu HR
    J Perinat Med; 1992; 20(6):437-41. PubMed ID: 1293269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of salbutamol in the treatment of severe hyperkalemia in hemodialysed patients].
    de Cornelissen F; Bermudes H; Saint-Loubert M; Marty L; Emond C; Fontanier P
    Presse Med; 1989 Jun; 18(25):1243-4. PubMed ID: 2525773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hyperkalaemia.
    Maxwell AP; Linden K; O'Donnell S; Hamilton PK; McVeigh GE
    J R Coll Physicians Edinb; 2013; 43(3):246-51. PubMed ID: 24087806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe?
    Mandelberg A; Krupnik Z; Houri S; Smetana S; Gilad E; Matas Z; Priel IE
    Chest; 1999 Mar; 115(3):617-22. PubMed ID: 10084465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental hyperkalaemia in rabbits: effects of salbutamol and norepinephrine treatments on blood biochemistry and electrocardiography.
    Celik S; Bal R; Durgut R
    Acta Vet Hung; 2003; 51(3):331-42. PubMed ID: 14516161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin glucose infusion versus nebulised salbutamol versus combination of salbutamol and insulin glucose in acute hyperkalaemia in the emergency room: protocol for a randomised, multicentre, controlled study (INSAKA).
    Montassier E; Lemoine L; Hardouin JB; Rossignol P; Legrand M
    BMJ Open; 2020 Aug; 10(8):e039277. PubMed ID: 32847923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for non-oliguric hyperkalaemia in preterm neonates.
    Vemgal P; Ohlsson A
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005257. PubMed ID: 17253550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salbutamol versus cation-exchange resin (kayexalate) for the treatment of nonoliguric hyperkalemia in preterm infants.
    Yaseen H; Khalaf M; Dana A; Yaseen N; Darwich M
    Am J Perinatol; 2008 Mar; 25(3):193-7. PubMed ID: 18425722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hyperkalemia in children with intravenous salbutamol.
    Noyan A; Anarat A; Pirti M; Yurdakul Z
    Acta Paediatr Jpn; 1995 Jun; 37(3):355-7. PubMed ID: 7645387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potassium-lowering effect of albuterol for hyperkalemia in renal failure.
    Montoliu J; Lens XM; Revert L
    Arch Intern Med; 1987 Apr; 147(4):713-7. PubMed ID: 3827459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study.
    Liou HH; Chiang SS; Wu SC; Huang TP; Campese VM; Smogorzewski M; Yang WC
    Am J Kidney Dis; 1994 Feb; 23(2):266-71. PubMed ID: 8311086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correction of hyperkalemia with intravenous salbutamol in children with chronic renal insufficiency].
    Arias-Reyes JA; Matos-Martínez M; Velásquez-Jones L; Dubey-Ortega LA
    Bol Med Hosp Infant Mex; 1989 Sep; 46(9):603-6. PubMed ID: 2604875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis and therapy of non-oliguric hyperkalaemia of the premature infant.
    Mildenberger E; Versmold HT
    Eur J Pediatr; 2002 Aug; 161(8):415-22. PubMed ID: 12172823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.